Nagaoka K, Chinen Y, Takegami T, Nabeya N, Sakurami T, Imura H, Kuno S, Tasaka K, Hamajima Y
Endocrinol Jpn. 1979 Oct;26(5):527-32. doi: 10.1507/endocrj1954.26.527.
The 125I-C1q binding test for the detection of soluble immune complexes in native unheated human serum was applied to the study of sera from 52 patients with diabetes mellitus in childhood. This radiolabeled C1q binding test is more sensitive and reproducible among the various methods proposed for the detection of immune complexes. The 125I-C1q binding activity in 52 sera from diabetes mellitus in childhood was 9.47 +/- 0.36% compared to 6.94 +/- 0.74% in normal controls. 125I-C1q binding values in diabetes mellitus in childhood were significantly higher than normal controls. Slight high values were seen in 3 patients with positive anti-DNA-antibodies in diabetes mellitus in childhood. 125I-C1q binding was not significantly increased in patients with positive antithyroid antibodies and insulin antibodies. There was no significant correlation between the duration of diabetes and 125I-C1q binding activity.
采用¹²⁵I - C1q结合试验检测天然未加热人血清中的可溶性免疫复合物,对52例儿童糖尿病患者的血清进行了研究。在已提出的检测免疫复合物的各种方法中,这种放射性标记的C1q结合试验更敏感且可重复。52例儿童糖尿病患者血清中的¹²⁵I - C1q结合活性为9.47±0.36%,而正常对照组为6.94±0.74%。儿童糖尿病患者的¹²⁵I - C1q结合值显著高于正常对照组。3例儿童糖尿病患者抗DNA抗体阳性,其¹²⁵I - C1q结合值略高。抗甲状腺抗体和胰岛素抗体阳性的患者,¹²⁵I - C1q结合未显著增加。糖尿病病程与¹²⁵I - C1q结合活性之间无显著相关性。